Filter
908
Text search:
MDR-TB
Featured
Recommendations
91
New Publications
243
Language
Document type
No document type
688
Studies & Reports
76
Guidelines
66
Manuals
20
Strategic & Response Plan
19
Fact sheets
15
Situation Updates
14
Training Material
7
Infographics
2
Resource Platforms
1
Countries / Regions
Western and Central Europe
62
Eastern Europe
47
India
36
South Africa
23
Kenya
22
Namibia
17
Ukraine
17
Tanzania
16
Nepal
15
Malawi
15
Myanmar / Burma
15
Ethiopia
14
Bangladesh
14
Zambia
13
Uganda
12
Rwanda
12
Latin America and the Carribbean
12
Asia
12
Cambodia
11
Lesotho
9
South–East Asia Region
9
Russia
9
Liberia
8
Nigeria
8
Ghana
8
Indonesia
7
Botswana
7
Global
7
Sierra Leone
6
Mozambique
6
Philippines
5
Germany
5
Colombia
5
Tajikistan
5
Senegal
4
Zimbabwe
4
Guinea
3
Congo, Democratic Republic of
3
Benin
3
Argentina
3
Peru
3
Eswatini/ Swaziland
3
Bhutan
3
Armenia
3
Timor Leste/ East Timor
3
Georgia
3
Burkina Faso
2
Pakistan
2
Central African Republic
2
Madagascar
2
Sri Lanka
2
Paraguay
2
Venezuela
2
Albania
2
Moldova
2
Vietnam
2
Cameroon
1
Somalia
1
South Sudan
1
Afghanistan
1
Gambia
1
El Salvador
1
Bolivia
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Africa
1
North Korea
1
Estonia
1
Kazakhstan
1
Turkmenistan
1
Maldives
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
321
Clinical Guidelines
84
Public Health
28
Key Resources
10
Capacity Building
8
Women & Child Health
7
Pharmacy & Technologies
7
Toolboxes
TB
502
HIV
80
AMR
34
Polio
20
Refugee
14
NTDs
10
Conflict
8
Ebola & Marburg
7
Global Health Education
7
Pharmacy
7
Rapid Response
4
COVID-19
4
Caregiver
4
Health Financing Toolbox
3
Disability
2
Natural Hazards
2
Mental Health
2
NCDs
2
2.0 Rapid Response
2
Specific Hazards
1
Planetary Health
1
For full publication see: https://drtbnetwork.org/tracking-tool-tb-patients-who-meet-criteria-be-screened-mdr-tb
This tracking tool is intended to ensure appropriate microbiologic screening for a
...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for
...
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio
...
Tuberculosis MDR-TB & XDR-TB The 2008 Report
For full course visit: https://drtbnetwork.org/training-course-MDR-TB
This course has been designed to take three days. It is composed of lectures, in-class readings, exercises, case discussions, a
...
This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis (TB) using molecular typing data reported by European Union (EU)/European Economic Area (EEA) Member States for 2015 and the preceding years.
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the prop
...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/
...
Adapted from a fact sheet on TB from the International Council of Nurse’s Global TB/MDR-TB Resource Centre at: http://www.icn.ch/tb/stigma.htm.
Accessed November 2017
Rev Panam Salud Publica. 2021;45:e74.
Some characteristics of patients and healthcare providers influence treatment success in MDR-TB cases. Physicians’ and nurses’ knowledge about
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regim
...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate
...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)
...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the
...
Tuberculosis (TB) is an infectious disease that usually affects the lungs, though it can affect any organ in the body. It can develop when bacteria spread through droplets in the air. TB can be fatal, but in many cases, TB is preventable and treatable. This report examines the human rights impact of
...
